re: Ann: Neuren places $3m of rights issue sh... CHawkey, the game is in play. no worry about too hard too soon. Its all underway.
No backing off now. Two drugs in phase 2 trials.
No competitors, No toxicity,
NNZ-2566 has the easiest Phase 3 . In this case Phase 2 is the big deal. pass that and we are heading for BLOCKBUSTER status.
And we have 10 uses for the drug. That is. One drug X Ten Blockbusters.
Have a good read about this. Injectile $2 Billion. Oral $ 2 Billion.
Eight more uses.
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AEF (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.85 |
Change
-0.070(1.42%) |
Mkt cap ! $483.8M | |||
| Open | High | Low | Value | Volume |
| $4.97 | $4.97 | $4.84 | $643.8K | 131.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1490 | $4.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.91 | 490 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| AEF (ASX) Chart |
